Article
Serologic and molecular investigations of DAR1 (weak D Type 4.2), DAR1.2, DAR1.3, DAR2 (DARE), and DARA. Lejon Crottet S, Haer-Wigman L, Gowland P, Fontana S, Niederhauser C, Hustinx H. Transfusion, 2013. [Citation]
Remark: including sample 3424 from the initial publication; including the three initial samples DARE I, DARE II and DARE III samples from
Annotations by Allele
- RHD*602G,667G,1025C (weak D type 4.2.0, DAR1.00): Prevalence
- RHD*602G,667G,697C,744T,957A,1025C (DAR2.01): Density
- RHD*602G,667G,697C,744T,957A,1025C (DAR2.01): Density
- RHD*602G,667G,697C,744T,957A,1025C (DAR2.01): Serology (overlaps with
16584437 ) - RHD*602G,667G,697C,744T,957A,1025C (DAR2.01): Density
- RHD*602G,667G,697C,744T,957A,1025C (DAR2.01): otherHaplotype (same samples as
16584437 , not counted twice) - RHD*602G,667G,697C,744T,957A,1025C (DAR2.01): Prevalence
- RHD*602G,667G,697C,957A,1025C (DAR2.00): Prevalence
- RHD*602G,667G,744T,1025C (weak D type 4.2.3, DAR1.03): Serology
- RHD*602G,667G,744T,1025C (weak D type 4.2.3, DAR1.03): otherHaplotype
- RHD*602G,667G,744T,1025C (weak D type 4.2.3, DAR1.03): Prevalence
- RHD*602G,667G,744T,957A,1025C (weak D type 4.2.2, DAR1.02): Serology
- RHD*602G,667G,744T,957A,1025C (weak D type 4.2.2, DAR1.02): otherHaplotype
- RHD*602G,667G,744T,957A,1025C (weak D type 4.2.2, DAR1.02): Density
- RHD*602G,667G,744T,957A,1025C (weak D type 4.2.2, DAR1.02): Density
- RHD*602G,667G,744T,957A,1025C (weak D type 4.2.2, DAR1.02): Density
- RHD*602G,667G,744T,957A,1025C (weak D type 4.2.2, DAR1.02): Prevalence
- RHD*DIIIa-CEVS(4-7)-D (RHD*03N.01): otherHaplotype